KRISTIN HUNTLEY: Open Payments
NPI 1972160984 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 37 payments from 12 companies in 2025. Trend: 2023 $199 · 2024 $236 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $173 |
| GlaxoSmithKline, LLC. | 7 | $118 |
| Novo Nordisk Inc | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $85 |
| Amgen Inc. | 3 | $46 |
| Stryker Corporation | 1 | $44 |
| Ardelyx, Inc. | 1 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 4 | $27 |
| Averitas Pharma Inc. | 1 | $24 |
Products named: UBRELVY, BREZTRI, TRELEGY ELLIPTA, Ozempic, SHINGRIX, OTEZLA, CLOTTRIEVER BOLD CATHETER, LINZESS.
Industry payments across SC — which companies pay providers there.
